Companies
RNS
Signals
Macro
Squawk
Research
Indices
Ticker TV
Events
Commodities
Currencies

· Data products

RNS Signals Research Squawk Macro TV Events

Developer Portal Market data Services

Overview Central banks RNS Book a demo

‌

Akari Therapeutics plc (AKTX) on NASDAQ CAPITAL MARKET | Ticker

/Exchanges/XNCM/AKTX

Akari Therapeutics plc

XNCM:AKTX — listed on NASDAQ CAPITAL MARKET

Overview Financials

About Akari Therapeutics plc

Website: www.akaritx.com
Issuer profile: All listings

Financial Summary

Operating Profit:	-$17.3M
Profit After Tax:	-$17.3M
Total Assets:	$47.9M
Shareholders' Equity:	$28.3M
Current Ratio:	0.44
Operating Cash Flow:	-$10.6M

As at Dec 20258 years of data

Listing details

Symbol: AKTX
Venue: NASDAQ CAPITAL MARKET
Segment MIC: XNCM
ISIN: US00972G4055
Trading currency: USD